SCHEDULE: Edmond de Rothschild Entities Disclose Significant Stake in Pacific Biosciences

Edmond de Rothschild Asset Management entities and Edmond de Rothschild Fund have disclosed beneficial ownership of up to 4.5% of Pacific Biosciences of California, Inc. common stock as of June 30, 2025.

Summary

• EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) reported beneficial ownership of 13,366,200 shares of Pacific Biosciences of California, Inc. common stock, representing 4.5% of the class.
• EDMOND DE ROTHSCHILD ASSET MANAGEMENT (LUXEMBOURG) reported beneficial ownership of 12,081,800 shares, representing 4.0% of the common stock.
• Edmond de Rothschild Fund also reported beneficial ownership of 12,081,800 shares, representing 4.0% of the common stock.
• The shares are held in the ordinary course of business and were not acquired for the purpose of or with the effect of changing or influencing the control of the issuer.
• The beneficial ownership was reported as of June 30, 2025.

Sentiment

Score: 7

Explanation: The disclosure of significant beneficial ownership by reputable institutional investors like Edmond de Rothschild entities is generally viewed positively as it indicates confidence and long-term interest in the company's prospects, without suggesting an activist agenda.

Positives

• Increased institutional investor interest from Edmond de Rothschild entities, signaling confidence in Pacific Biosciences' long-term prospects.
• The investment is passive, indicating a long-term holding strategy rather than an activist stance, which can provide stability.

Future Outlook

This filing does not contain forward-looking statements or guidance from the issuer.

Industry Context

The disclosure reflects continued institutional investment in the biotechnology and life sciences sector, particularly in companies like Pacific Biosciences that are involved in advanced genomic sequencing technologies, indicating ongoing investor confidence in the sector's growth potential.

Stakeholder Impact

• Shareholders may view the increased institutional ownership as a positive signal, potentially leading to increased investor confidence and demand for the stock.

Key Dates

Keywords

Pacific Biosciences, Edmond de Rothschild, Beneficial Ownership, Institutional Investment, Common Stock, Biotechnology, Genomic Sequencing